Literature DB >> 21725211

Vesicle transfer and cell fusion: Emerging concepts of cell-cell communication in the tumor microenvironment.

T Kevin Howcroft1, Huang-Ge Zhang, Madhav Dhodapkar, Suresh Mohla.   

Abstract

Cell-cell fusion and vesicle-mediated transfer are fundamental biological processes that are emerging as novel mechanisms for re-programming cells in the tumor microenvironment. Both cell-cell fusion and intercellular transfer of vesicles (including microvesicles and exosomes) allow for the transfer of information among tumor cells, between tumor cells and tumor stroma, and between tumor cells and the host immune system, which could have profound implications for our understanding of tumor initiation and progression. The National Cancer Institute's Division of Cancer Biology sponsored a recent workshop (December 4-6, 2010) entitled, Vesicle Transfer and Cell Fusion: Emerging Concepts of Cell-Cell Communication in the Tumor Microenvironment to assess the current state of the science in these two scientific areas. Co-chaired by Drs. Huang-Ge Zhang (University of Louisville) and Madhav Dhodapkar (Yale University) this workshop brought together, for the first time at the NIH, leaders in the field to assess the effects of vesicle transfer and cell-cell fusion on cancer initiation, progression and metastasis. This meeting report includes brief summaries of the presentations and identifies the major questions, roadblocks, and opportunities. The meeting report is presented here to highlight research priorities and to stimulate basic and translational research efforts to better understand the contributions of cell-cell fusion and vesicle transfer to cancer.

Entities:  

Mesh:

Year:  2011        PMID: 21725211      PMCID: PMC3230480          DOI: 10.4161/cbt.12.3.17032

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  11 in total

1.  Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins.

Authors:  Caroline Subra; David Grand; Karine Laulagnier; Alexandre Stella; Gérard Lambeau; Michael Paillasse; Philippe De Medina; Bernard Monsarrat; Bertrand Perret; Sandrine Silvente-Poirot; Marc Poirot; Michel Record
Journal:  J Lipid Res       Date:  2010-04-27       Impact factor: 5.922

2.  Exosomes and cancer: a newly described pathway of immune suppression.

Authors:  Huang-Ge Zhang; William E Grizzle
Journal:  Clin Cancer Res       Date:  2011-01-11       Impact factor: 12.531

3.  Dominant role of CD47-thrombospondin-1 interactions in myeloma-induced fusion of human dendritic cells: implications for bone disease.

Authors:  Anjli Kukreja; Soroosh Radfar; Ben-Hua Sun; Karl Insogna; Madhav V Dhodapkar
Journal:  Blood       Date:  2009-08-06       Impact factor: 22.113

4.  Fusion between Intestinal epithelial cells and macrophages in a cancer context results in nuclear reprogramming.

Authors:  Anne E Powell; Eric C Anderson; Paige S Davies; Alain D Silk; Carl Pelz; Soren Impey; Melissa H Wong
Journal:  Cancer Res       Date:  2011-02-08       Impact factor: 12.701

Review 5.  Cell-to-cell fusion as a link between viruses and cancer.

Authors:  Dominik Duelli; Yuri Lazebnik
Journal:  Nat Rev Cancer       Date:  2007-12       Impact factor: 60.716

6.  CD200 and its receptor, CD200R, modulate bone mass via the differentiation of osteoclasts.

Authors:  Weiguo Cui; Esteban Cuartas; Juan Ke; Qing Zhang; Halldor B Einarsson; Jonathon D Sedgwick; Jun Li; Agnès Vignery
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-28       Impact factor: 11.205

7.  ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles.

Authors:  Vandhana Muralidharan-Chari; James Clancy; Carolyn Plou; Maryse Romao; Philippe Chavrier; Graca Raposo; Crislyn D'Souza-Schorey
Journal:  Curr Biol       Date:  2009-11-05       Impact factor: 10.834

8.  Organ-specific enhancement of metastasis by spontaneous ploidy duplication and cell size enlargement.

Authors:  Xin Lu; Xuemin Lu; Yibin Kang
Journal:  Cell Res       Date:  2010-07-13       Impact factor: 25.617

9.  Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg).

Authors:  Marta Szajnik; Malgorzata Czystowska; Miroslaw J Szczepanski; Magis Mandapathil; Theresa L Whiteside
Journal:  PLoS One       Date:  2010-07-22       Impact factor: 3.240

10.  Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers.

Authors:  Johan Skog; Tom Würdinger; Sjoerd van Rijn; Dimphna H Meijer; Laura Gainche; Miguel Sena-Esteves; William T Curry; Bob S Carter; Anna M Krichevsky; Xandra O Breakefield
Journal:  Nat Cell Biol       Date:  2008-11-16       Impact factor: 28.824

View more
  7 in total

1.  Kinins in Glioblastoma Microenvironment.

Authors:  Mona N Oliveira; Barbara Breznik; Micheli M Pillat; Ricardo L Pereira; Henning Ulrich; Tamara T Lah
Journal:  Cancer Microenviron       Date:  2019-08-16

Review 2.  Mesenchymal Stem Cell (MSC)-Derived Extracellular Vesicles: Potential Therapeutics as MSC Trophic Mediators in Regenerative Medicine.

Authors:  Qi-Ling Yuan; Yin-Gang Zhang; Qian Chen
Journal:  Anat Rec (Hoboken)       Date:  2019-06-17       Impact factor: 2.064

Review 3.  Extracellular vesicles: lipids as key components of their biogenesis and functions.

Authors:  Michel Record; Sandrine Silvente-Poirot; Marc Poirot; Michael J O Wakelam
Journal:  J Lipid Res       Date:  2018-05-15       Impact factor: 5.922

4.  Kinin-B1 Receptor Stimulation Promotes Invasion and is Involved in Cell-Cell Interaction of Co-Cultured Glioblastoma and Mesenchymal Stem Cells.

Authors:  Mona N Oliveira; Micheli M Pillat; Helena Motaln; Henning Ulrich; Tamara T Lah
Journal:  Sci Rep       Date:  2018-01-22       Impact factor: 4.379

5.  Exploration of the Proteomic Landscape of Small Extracellular Vesicles in Serum as Biomarkers for Early Detection of Colorectal Neoplasia.

Authors:  Li-Chun Chang; Yi-Chiung Hsu; Han-Mo Chiu; Koji Ueda; Ming-Shiang Wu; Chiun-How Kao; Tang-Long Shen
Journal:  Front Oncol       Date:  2021-09-13       Impact factor: 6.244

Review 6.  NANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?

Authors:  Sten Friberg; Andreas M Nyström
Journal:  J Nanobiotechnology       Date:  2016-03-09       Impact factor: 10.435

7.  Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial.

Authors:  Ines Stevic; Volkmar Müller; Karsten Weber; Peter A Fasching; Thomas Karn; Frederic Marmé; Christian Schem; Elmar Stickeler; Carsten Denkert; Marion van Mackelenbergh; Christoph Salat; Andreas Schneeweiss; Klaus Pantel; Sibylle Loibl; Michael Untch; Heidi Schwarzenbach
Journal:  BMC Med       Date:  2018-10-10       Impact factor: 8.775

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.